Olfaction in the Psychosis Prodrome: Behavioral and ERP Measures
Olfaction in the Psychosis Prodrome: Behavioral and ERP Measures
批准号:
7806529
负责人:
GERARD E BRUDER
金额:
$19.99万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-17 至 2012-01-31
关键词:
Affective SymptomsAgeAnxietyAttenuatedAuditoryAwardBehavioralBiological MarkersChronic DiseaseClinicalClinical ResearchCognitionCognitiveDataDetectionDiseaseEarly treatmentEmotionsEmployee StrikesEnrollmentEvent-Related PotentialsExploratory/Developmental GrantFaceFamily memberFunctional disorderFundingGenderHousingHydrogen SulfideIndividualInferiorInstitutesInterventionInterviewerLaboratoriesLeadMeasuresMedialMemoryMemory impairmentMentorsMethodsModalityMorbidity - disease rateNew YorkOdorsPalliative CareParietalPatientsPharmaceutical PreparationsPositioning AttributePredictive ValuePrincipal Component AnalysisProcessPsychopathologyPsychophysiologyPsychotic DisordersRadialResearchResearch PersonnelRiskRoleSchizophreniaSmell PerceptionSocial FunctioningSourceSpecificitySurfaceSymptomsTechniquesUniversitiesauditory stimulusbasecognitive functioncohortdensitydisabilityhigh riskimprovedneurophysiologyolfactory stimulusolfactory thresholdpreventprogramspublic health relevanceresponsesocialsocial cognitiontherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Olfactory function is disturbed in schizophrenia, as identified by behavioral markers (smell identification and odor threshold) and olfactory event-related potentials (OERPs). These disturbances are also present in unaffected family members, which make them good candidates as potential biomarkers of schizophrenia risk. Smell identification deficits were found to discriminate who among high-risk cases will actually develop schizophrenia. Little is, however, known about the underlying pathophysiology of emerging psychosis during the prodromal period. This R21 application brings together clinical researchers doing prodromal studies and investigators with expertise in cognitive and electrophysiologic studies in schizophrenia. The proposed study will use improved methods for ERP analyses and for identifying at-risk young people so as to evaluate in cross-section behavioral and electrophysiological measures of olfactory function in prodromal patients, and their association with symptom features and measures of social and cognition function. If olfactory ERPs are found to be abnormal in prodromal patients, we will then apply for an R01 to evaluate whether olfactory ERPs in a prodromal cohort may be a biomarker of conversion to schizophrenia. ERPs and behavioral detection responses will be measured in 30 prodromal patients and 30 matched healthy controls to three concentrations of hydrogen sulfide during a detection task. This will take advantage of existing methods for precise control of olfactory stimuli (olfactometer) and also new data analytic techniques in the electrophysiologic domain. Current source density (CSD; surface Laplacian) and temporal principal components analysis (PCA) are combined to yield reference-free measures of radial current flow corresponding to meaningful olfactory ERP components. Auditory ERPs will also be measured during a novelty oddball detection task so as to begin to examine the modality specificity of olfactory ERP deficits. Interviewer-based and self-ratings of psychopathology, measures of social function, facial emotion recognition, and cognitive function will be used to examine the relation of ERP and behavioral olfactory deficits in patients to prodromal symptoms, social function, and cognition. PUBLIC HEALTH RELEVANCE: From a clinical perspective, the study of prodromal patients is of importance not only for discovering markers for predicting conversion to schizophrenia but also for the potential development of treatments that would precede the onset of psychosis. Identification of a risk biomarker could lead to a lower rate of false positives in prodromal research and perhaps protect young people against unnecessary medication exposure.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/eip.12047
发表时间:
2014-08
期刊:
Early intervention in psychiatry
影响因子:
2
作者:
[Anglin DM, Greenspoon MI, Lighty Q, Corcoran CM, Yang LH]
通讯作者:
Yang LH
DOI:
10.1176/ps.2009.60.6.812
发表时间:
2009-06
期刊:
Psychiatric services (Washington, D.C.)
影响因子:
--
作者:
[Gerson R, Davidson L, Booty A, McGlashan T, Malespina D, Pincus HA, Corcoran C]
通讯作者:
Corcoran C
DOI:
10.1016/j.bpsc.2016.12.008
发表时间:
2017-11
期刊:
Biological psychiatry. Cognitive neuroscience and neuroimaging
影响因子:
--
作者:
[Colibazzi T, Yang Z, Horga G, Chao-Gan Y, Corcoran CM, Klahr K, Brucato G, Girgis R, Abi-Dargham A, Milham MP, Peterson BS]
通讯作者:
Peterson BS
DOI:
10.1038/mp.2017.249
发表时间:
2018-08
期刊:
Molecular psychiatry
影响因子:
11
作者:
[Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, Javitt D, Kantrowitz J, Wall MM, Corcoran CM, Schobel SA, Small SA]
通讯作者:
Small SA
Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.
情绪识别缺陷是精神分裂症临床高风险的个体过渡的预测因素:神经发育的观点。
DOI:
10.1017/s0033291715000902
发表时间:
2015-10
期刊:
PSYCHOLOGICAL MEDICINE
影响因子:
6.9
作者:
[Corcoran, C. M., Keilp, J. G., Kayser, J., Klim, C., Butler, P. D., Bruder, G. E., Gur, R. C., Javitt, D. C.]
通讯作者:
Javitt, D. C.
共 7 条
Time-Frequency Measures for Predicting Response to Antidepressants
-
批准号:8301517
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2011
-
负责人:GERARD E BRUDER
-
依托单位:
Time-Frequency Measures for Predicting Response to Antidepressants
-
批准号:8158612
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2011
-
负责人:GERARD E BRUDER
-
依托单位:
Olfaction in the Psychosis Prodrome: Behavioral and ERP Measures
-
批准号:7647847
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2009
-
负责人:GERARD E BRUDER
-
依托单位:
Subtypes of Schizophrenia: ERPs During Memory Processing
-
批准号:6722440
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2003
-
负责人:GERARD E BRUDER
-
依托单位:
Subtypes of Schizophrenia: ERPs During Memory Processing
-
批准号:6984066
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2003
-
负责人:GERARD E BRUDER
-
依托单位:
Subtypes of Schizophrenia: ERPs During Memory Processing
-
批准号:7155495
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2003
-
负责人:GERARD E BRUDER
-
依托单位:
Subtypes of Schizophrenia: ERPs During Memory Processing
-
批准号:6820644
-
项目类别:
-
资助金额:$36.36万
-
财政年份:2003
-
负责人:GERARD E BRUDER
-
依托单位:
Subtypes of Schizophrenia: ERPs During Memory Processing
-
批准号:7324824
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2003
-
负责人:GERARD E BRUDER
-
依托单位:
MULTIUSER GEODESIC SENSOR NET EEG/ERP SYSTEM
-
批准号:2503030
-
项目类别:
-
资助金额:$18.98万
-
财政年份:1998
-
负责人:GERARD E BRUDER
-
依托单位:
BRAIN ERPS AND COGNITIVE DEMAND IN SCHIZOPHRENIA
-
批准号:2883371
-
项目类别:
-
资助金额:$23.18万
-
财政年份:1994
-
负责人:GERARD E BRUDER
-
依托单位:
BRAIN ERPS AND COGNITIVE DEMAND IN SCHIZOPHRENIA
-
批准号:2250059
-
项目类别:
-
资助金额:$18.32万
-
财政年份:1994
-
负责人:GERARD E BRUDER
-
依托单位:
BRAIN ERPS AND COGNITIVE DEMAND IN SCHIZOPHRENIA
-
批准号:2471660
-
项目类别:
-
资助金额:$24.1万
-
财政年份:1994
-
负责人:GERARD E BRUDER
-
依托单位:
BRAIN ERPS AND COGNITIVE DEMAND IN SCHIZOPHRENIA
-
批准号:2250061
-
项目类别:
-
资助金额:$18.65万
-
财政年份:1994
-
负责人:GERARD E BRUDER
-
依托单位:
BRAIN ERPS AND COGNITIVE DEMAND IN SCHIZOPHRENIA
-
批准号:2250060
-
项目类别:
-
资助金额:$17.8万
-
财政年份:1994
-
负责人:GERARD E BRUDER
-
依托单位:
BRAIN ERPS AND COGNITIVE DEMAND IN SCHIZOPHRENIA
-
批准号:6165155
-
项目类别:
-
资助金额:$23.88万
-
财政年份:1994
-
负责人:GERARD E BRUDER
-
依托单位:
BRAIN ERPS AND COGNITIVE DEMAND IN SCHIZOPHRENIA
-
批准号:6363652
-
项目类别:
-
资助金额:$24.58万
-
财政年份:1994
-
负责人:GERARD E BRUDER
-
依托单位:
BRAIN ERPS AND COGNITIVE DEMAND IN SCHIZOPHRENIA
-
批准号:6530842
-
项目类别:
-
资助金额:$25.32万
-
财政年份:1994
-
负责人:GERARD E BRUDER
-
依托单位:
BEHAVIORAL, ERP AND EEG ASYMMETRY IN AFFECTIVE DISORDERS
-
批准号:2244478
-
项目类别:
-
资助金额:$18.71万
-
财政年份:1982
-
负责人:GERARD E BRUDER
-
依托单位:
BEHAVIORAL, ERP AND EEG ASYMMETRY IN AFFECTIVE DISORDERS
-
批准号:2033598
-
项目类别:
-
资助金额:$21.19万
-
财政年份:1982
-
负责人:GERARD E BRUDER
-
依托单位:
BEHAVIORAL, ERP AND EEG ASYMMETRY IN AFFECTIVE DISORDERS
-
批准号:6903606
-
项目类别:
-
资助金额:$27.87万
-
财政年份:1982
-
负责人:GERARD E BRUDER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: